Mr. Dilip Shanghvi, took a 99% cut in his remuneration in 2018-19 when the Sun Pharma earnings grew by 27%.
Among peers, Shanghvi was one of the lowest-paid CEOs. His remuneration in 2017-18 was Rs 3.36 crore (including a salary of Rs 2.79 cr). He drew a salary of ~ Rs 1/- during 2018-19 as per Sun Pharma’s annual report.
The valuation of Dilip Shanghvi shareholding which is 9.6 % in Sun Pharma on 31st July 2019 was Rs. 9830 crore.